Denali Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,900
Closed -$202K 491
2023
Q2
$202K Buy
+9,900
New +$202K 0.07% 213